Recent Publications
Manny JS, Pardee T, Pettenati M, Pang CS.
Near-tetraploid/tetraploid acute myeloid leukemia: morphologic, cytogenetic, and prognostic features [abstract]. Mod Pathol.
2012;
25(Suppl 2):354A.
Ware P, Snow A, Pettenati M, Qasem S.
MDM2 copy numbers in well differentiated and dedifferentiated liposarcoma: where do we draw the line? [abstract]. Mod Pathol.
2012;
25(Suppl 2):22A.
Edwards CG, Maharry K, Mrozek K, Schwind S, Paschka P, Nicolet D, Kohlschmidt J, Prior TW, Wu Y-Z, Kolitz JE, Blum W, Pettenati MJ, Cin PD, Carroll AJ, Caligiuri MA, Larson RA, Marcucci G, Bloomfield CD.
Cytogenetic, molecular and clinical features associated with rare CBFB-MYH11 fusion transcripts in patients (Pts) with acute myeloid leukemia (AML) and inv(16)/t(16;16 [abstract]. Blood.
2011;
118(21):1077.
Mrozek K, Marcucci G, Maharry K, Nicolet D, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu Y-Z, Kohlschmidt J, Pettenati MJ, Koduru PRK, Heerema NA, Block AW, Patil SR, Baer MR, Kolitz JE, Moore JO, Carroll AJ, Larson RA, Bloomfield CD.
Prognostic utility of the European LeukemiaNet (ELN) genetic-risk classification in adults with de novo acute myeloid leukemia (AML): a study of 1,550 patients (Pts) [abstract]. Blood.
2011;
118(21 Suppl):190-191.
Beaty MW, Pettenati M, Hurd DH [sic] [Hurd DD], Keung Y.
Possible role of engraftment syndrome in myelodysplastic syndrome after autologous transplants [abstract]. Mod Pathol.
2009;
22(Suppl 1):1161.
Korbel JO, Tirosh-Wagner T, Urban AE, Chen X-N, Kasowski M, Dai L, Grubert F, Erdman C, Gao MC, Pettenati MJ, et al.
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci U S A.
2009;
106(29):12031-36.
Mrozek K, Holland KB, Pettenati MJ, Maharry K, Marcucci G, Baer MR, Kolitz JE, Margeson D, Edwards CG, Carroll AJ, et al.
Prognostic significance of unbalanced chromosome abnormalities used by 2008 World Health Organization (WHO) classification to define 'acute myeloid leukemia (AML) with myelodysplasia-. Blood.
2009;
114(22):1021.
Keung Y, Beaty MW, Pettenati M, Levitan D, Molnar I, Thakuri M, Cruz J, Hurd DD.
Possible role of engraftment syndrome in myelodysplastic syndrome after autologous transplants [abstract]. J Clin Oncol.
2008;
26(Suppl):a18016.
Mrozek K, Carroll AJ, Maharry K, Rao KW, Patil SR, Pettenati MJ, Watson MS, Arthur DC, Tantravahi R, Heerema NA, et al.
Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: the Cancer and Leukemia Group B experience. Int J Oncol.
2008;
33(2):239-244.
Keung YK, Beaty MW, Pettenati M, Levitan D, Molnar I, Thakuri MC, Cruz J, Hurd DD.
Possible role of engraftment syndrome in myelodysplastic syndrome after autologous transplants [abstract]. Blood.
2008;
112(11):751.
Chauvenet AR, Martin PL, Devidas M, Linda SB, Bell BA, Kurtzberg J, Pullen J, Pettenati MJ, Carroll AJ, Shuster JJ, et al.
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood.
2007;
110(4):1105-1111.
Heerema NA, Raimondi SC, Anderson JR, Biegel J, Camitta BM, Cooley LD, Gaynon PS, Hirsch B, Magenis RE, Pettenati MJ, et al.
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes Cancer.
2007;
46(7):684-693.
Hatchwell E, Tegay DH, Wang C, O'Brien JE, Allen W, Tan T, Prucka S, Pettenati MJ, Montagna C, Nowak MJ, et al.
Genetic dissection using a novel whole genome tiling path BAC array reveals dramatic heterogeneity in Toriello-Carey syndrome, including a novel microdeletion syndrome at 22q12 [abstract]. Cell Oncol.
2007;
29(2):143.
Gastier-Foster JM, Carroll AJ, Ell D, Harvey R, Chen IM, Ketterling R, Meloni-Ehring A, Opheim KE, Pettenati M, et al.
Two distinct subsets of dic(9;12)(p12;p11.2) among children with B-cell precursor acute lymphoblastic leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 rearrangements: a report from the Children's Oncology Group [abstract]. Blood.
2007;
110(11 Pt 1):431A.
Farag SS, Archer KJ, Mrozek K, Ruppert AS, Carroll AJ, Vardiman JW, Pettenati MJ, Baer MR, Qumsiyeh MB, Koduru PR, et al.
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Blood.
2006;
108(1):63-73.
Graf MD, Christ L, Mascarello JT, Mowrey P, Pettenati M, Stetten G, Storto P, Surti U, Van Dyke DL, Vance GH, et al.
Redefining the risks of prenatally ascertained supernumerary marker chromosomes: a collaborative study. J Med Genet.
2006;
43(8):660-664.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.